These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4226327)
1. The inhibitory effect of protoporphyrin on the fibrinolytic system in vitro. Suyama T; Iga Y; Kawano T Biochim Biophys Acta; 1966 Sep; 127(1):258-60. PubMed ID: 4226327 [No Abstract] [Full Text] [Related]
2. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE). JAMES DC; BROWSE NL Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065 [No Abstract] [Full Text] [Related]
3. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT. COON WW Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774 [No Abstract] [Full Text] [Related]
4. [Physiology of hemostasis. II. Fibrinolysis]. Sultan Y; Caen J; Allain JP; Meyer D Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805 [No Abstract] [Full Text] [Related]
5. The susceptibility of plasma to activation of fibrinolysis. Stief TW Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639 [TBL] [Abstract][Full Text] [Related]
6. [On thrombolysis with various thrombolytic agents. I. Studies on experimental human natural blood clots]. Schmidt HW Klin Wochenschr; 1966 Jun; 44(11):618-21. PubMed ID: 4229084 [No Abstract] [Full Text] [Related]
7. [Long-lasting activation of the fibrinolytic system in blood and its clinical application]. Bielawiec M Pol Tyg Lek; 1969 Jan; 24(2):63-6. PubMed ID: 4240415 [No Abstract] [Full Text] [Related]
8. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
9. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma]. Okamoto U Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660 [No Abstract] [Full Text] [Related]
10. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
11. Fibrinolytic agents and their effects on the haemostatic system. Kluft C Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542 [TBL] [Abstract][Full Text] [Related]
12. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS. HECKER SP Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527 [TBL] [Abstract][Full Text] [Related]
13. An immunochemical study of human plasminogen and plasmin. Robbins KC; Summaria L Immunochemistry; 1966 Jan; 3(1):29-40. PubMed ID: 4223674 [No Abstract] [Full Text] [Related]
14. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex]. Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a sustained fibrinolytic response to anisoylated plasminogen streptokinase activator complex in vitro. Fears R Drugs; 1987; 33 Suppl 3():83-7. PubMed ID: 3315617 [No Abstract] [Full Text] [Related]
17. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state. Spöttl F; Holzknecht F Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466 [No Abstract] [Full Text] [Related]
19. Inhibitors of fibrinolysis. A comparative thrombelastographic study. Egeblad K Scand J Clin Lab Invest Suppl; 1967; 98():1-69. PubMed ID: 4228724 [No Abstract] [Full Text] [Related]
20. The fibrinolytic system and its pharmacologic activation for thrombolysis. Sherry S Cardiol Clin; 1987 Feb; 5(1):1-11. PubMed ID: 2951008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]